Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bouza

Showing results (211-220 of 2,165) with videos related to

Pageof 217
Sort By:
Plos One|February 20, 2019
The impact of dementia on hospital outcomes for elderly patients with sepsis: A population-based studyCarmen Bouza, Gonzalo Martínez-Alés, Teresa López-Cuadrado
Infectious Disease Clinics of North America|February 5, 2017
Microbiology and Epidemiology of Legionnaire's DiseaseAlmudena Burillo, María Luisa Pedro-Botet, Emilio Bouza
Mycoses|June 3, 2015
Antifungal stewardship in daily practice and health economic implicationsPatricia Muñoz, Maricela Valerio, Antonio Vena, et al.
The Journal of Infection|January 1, 1991
Ciprofloxacin as an effective antibacterial agent in serratia endocarditisJ Ena, C Amador, F Parras, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2003
In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesEmilia Cercenado, Sonia Cercenado, Juan A Gómez, et al.
Angiologia|January 1, 1971
[Kinks in the extracranial portions of the cerebral vessels, their role in the development of cerebral ischemia]P Brunet, P Beauballet, R Pereiras, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1995
In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infectionsJ Berenguer, V Fernández-Baca, R Sánchez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|October 1, 1996
[Monitoring anti-retroviral treatment]J M Miró, T Pumarola, V Soriano, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolatesF García-Garrote, E Cercenado, L Alcalá, et al.
Revista Espanola De Cardiologia|August 26, 1998
[Heart pathology of the extracardiac origin. X. Heart diseases of viral etiology]J M Eiros Bouza, P Martínez, A Rodríguez Torres
Pageof 217

Showing results (211-220 of 2,165) with videos related to

Sort By:
Pageof 217
Plos One|February 20, 2019
The impact of dementia on hospital outcomes for elderly patients with sepsis: A population-based studyCarmen Bouza, Gonzalo Martínez-Alés, Teresa López-Cuadrado
Infectious Disease Clinics of North America|February 5, 2017
Microbiology and Epidemiology of Legionnaire's DiseaseAlmudena Burillo, María Luisa Pedro-Botet, Emilio Bouza
Mycoses|June 3, 2015
Antifungal stewardship in daily practice and health economic implicationsPatricia Muñoz, Maricela Valerio, Antonio Vena, et al.
The Journal of Infection|January 1, 1991
Ciprofloxacin as an effective antibacterial agent in serratia endocarditisJ Ena, C Amador, F Parras, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2003
In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesEmilia Cercenado, Sonia Cercenado, Juan A Gómez, et al.
Angiologia|January 1, 1971
[Kinks in the extracranial portions of the cerebral vessels, their role in the development of cerebral ischemia]P Brunet, P Beauballet, R Pereiras, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1995
In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infectionsJ Berenguer, V Fernández-Baca, R Sánchez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|October 1, 1996
[Monitoring anti-retroviral treatment]J M Miró, T Pumarola, V Soriano, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolatesF García-Garrote, E Cercenado, L Alcalá, et al.
Revista Espanola De Cardiologia|August 26, 1998
[Heart pathology of the extracardiac origin. X. Heart diseases of viral etiology]J M Eiros Bouza, P Martínez, A Rodríguez Torres
Pageof 217